NEW DATA OF BLOOD TRANSFUSION IMPORTANCE IN PATHOLOGY
Loredana Liliana Hurjui, Ionela Lăcrămioara Șerban, Liliana Foia, Eusebiu Vlad Gorduza, Diana Popovici, Ion Hurjui, Minela Aida Maranducă, Roxana Paduraru, Irina Grădinaru
Abstract
Loredana Liliana Hurjui, Ionela Lăcrămioara Șerban, Liliana Foia, Eusebiu Vlad Gorduza, Diana Popovici, Ion Hurjui, Minela Aida Maranducă, Roxana Paduraru, Irina Grădinaru
Abstract
Blood transfusion is a very important aspect of clinical hematology. An essential particularity is the correctly use of blood products because it can cause immediate or delayed complications. Transfusion security and efficiency requires integrated strategies and the purpose of the transfusion is to provide the patient with blood components to improve their hematologic status. From a single total blood donation can be obtained multiple type of blood components. Transfusion centers are capable of separating plasma erythrocytes, or of other products such as platelet concentrates, or cryoprecipitate named 'labile blood products'. On the other side plasma derivates, are made by fractionation of plasma. All the blood components to bring benefit must be viable when transfused. The blood or the resulting compounds must be preserved, transported and stored under conditions that meet quality criteria and follow the standardized procedures.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Blood transfusion is a very important aspect of clinical hematology. An essential particularity is the correctly use of blood products because it can cause immediate or delayed complications. Transfusion security and efficiency requires integrated strategies and the purpose of the transfusion is to provide the patient with blood components to improve their hematologic status. From a single total blood donation can be obtained multiple type of blood components. Transfusion centers are capable of separating plasma erythrocytes, or of other products such as platelet concentrates, or cryoprecipitate named 'labile blood products'. On the other side plasma derivates, are made by fractionation of plasma. All the blood components to bring benefit must be viable when transfused. The blood or the resulting compounds must be preserved, transported and stored under conditions that meet quality criteria and follow the standardized procedures.
Key concepts: Cryoprecipitate, Blood transfusion, Medicine, Blood donor, Whole blood, Intensive care medicine, Autotransfusion, Blood component